China
· Delayed Price · Currency is CNY Shenzhen Chipscreen Biosciences Company Description
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs.
The company develops precursor compounds and original new drug product lines for the treatment of human diseases in five therapeutic areas, including cancer, metabolic diseases, autoimmune disorders, central nervous system disorders, and antivirals.
It is developing chidamide, a subtype-selective benzamide inhibitor of histone deacetylase (HDAC) primarily targeting subtypes 1, 2, 3 of class I HDAC; chiglitazar, a new-generation insulin sensitizing candidate drug for the treatment of type 2 diabetes mellitus; and chiauranib, an aurora B/VEGFR/PDGFR /c-Kit/CSF1R inhibitor.
The company also develops CS23546, a small molecule PD-L1 inhibitor for CS23546 is a small molecule PD-L1 inhibitor; CS32582, a highly selective small molecule allosteric inhibitor of tyrosine kinase 2; CS12192, a highly selective JAK3 kinase inhibitor; and other drugs, such as CS12088 and CS23074.
Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is headquartered in Shenzhen, China.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,057 |
| CEO | Xian-Ping Lu |
Contact Details
Address: Zhigu Industrial Park Shenzhen, 518057 China | |
| Phone | 86 755 2695 2070 |
| Website | chipscreen.com |
Stock Details
| Ticker Symbol | 688321 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003LW0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Xian-Ping Lu | Founder, Chairman, GM, Chief Executive Officer and President |
| Jian-Xun Li BA.CFA | Vice President, Deputy GM, Chief Financial Officer and Director |
| Dr. Desi Pan | Vice President, Deputy GM, Chief Scientific Officer and Head of the Early Research and Development Center |
| Ou Hai | Vice President, Deputy GM, Secretary of the Board, Head of Legal and Intellectual Property Department and Director |
| Dr. Zhi-Bin Li Ph.D. | Vice President, Deputy GM and Head of Product Development and Production |
| Liangji She | Vice President, Deputy GM and Head of Oncology Division |
| Libin Zhang | Vice President, Deputy GM and Head of Metabolic Diseases Division |
| Dr. Leming Shi | Co-Founder |
| Dr. Weiming Hu | Co-Founder |
| Ji-Hui Yi MS | Vice President of Sales and Marketing |